Trials / Completed
CompletedNCT01227369
Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,376 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Quality of Life (QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatment
Detailed description
Cross-sectional quality of life survey using self-administered OPSAT-QTM questionnaire in Korean postmenopausal osteoporosis patients with bisphosphonate treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | OPSAT-Q | A linguistically validated Korean version of OPSAT-Q |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2009-11-01
- Completion
- 2009-11-01
- First posted
- 2010-10-25
- Last updated
- 2017-06-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01227369. Inclusion in this directory is not an endorsement.